Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar 28:5:167.
doi: 10.1186/1756-0500-5-167.

Seroprevalence of hepatitis B e antigen (HBe antigen) and B core antibodies (IgG anti-HBcore and IgM anti-HBcore) among hepatitis B surface antigen positive blood donors at a Tertiary Centre in Nigeria

Akinsegun A Akinbami  1 , Olajumoke O Oshinaike, Owolabi A Dosunmu, Titilope A Adeyemo, Adewumi Adediran, Sulaiman Akanmu, Kikelomo O Wright, Seun Ilori, Kinsley Aile
Affiliations

Seroprevalence of hepatitis B e antigen (HBe antigen) and B core antibodies (IgG anti-HBcore and IgM anti-HBcore) among hepatitis B surface antigen positive blood donors at a Tertiary Centre in Nigeria

Akinsegun A Akinbami et al. BMC Res Notes. .

Abstract

Background: Hepatitis B virus (HBV) is a common cause of liver disease throughout the world. HBV is transmitted through blood and other body fluids, including semen and saliva. Chronic replication of HBV virons is characterized by persistence circulation of HBsAg, HBeAg and HBV DNA; usually with anti-HBc and occasionally with anti-HBs.

Aim: To determine the prevalence of HBeAg, IgG anti-HBcore and IgM anti-HBcore amongst HBsAg positive blood donors. These parameters are reflective of transmissibility and active hepatitis B infection. A cross sectional study was carried out at the blood donor clinics of Lagos State University Teaching Hospital Ikeja and Lagos University Teaching Hospital Idiaraba. A total of 267 donors were recruited to determine HBe antigen, IgG and IgM anti-HBcore antibodies amongst hepatitis BsAg positive donors. Five milliliters of blood was collected from those who tested positive to HBsAg screen during donation. The sera were subjected to enzyme linked immunosorbent assay (ELISA). Pearson chi-squared test was used for the analytical assessment.

Findings: A total number of 267 HBsAg positive blood donors were studied. A seroprevalence of 8.2% (22 of 267) HBeAg was obtained, 4 of 267 (1.5%) were indeterminate while 241 (90.3%) tested negative. Only 27 out of 267 donors (10.1%) tested positive to IgM anti-HBcore, 234(87.6%) tested negative, while 6(2.2%) were indeterminate. A higher percentage of 60.7% (162 of 267) tested positive to IgG anti-HBcore, while 39.3% (105 of 267) tested negative.

Conclusion: There is a low seroprevalence rate of HBeAg-positive chronic hepatitis and relatively high IgG anti-HBcore and IgM anti-HBcore rates in South West Nigeria.

PubMed Disclaimer

References

    1. Lok AS. Chronic hepatitis B. N Eng J Med. 2002;346:1682–1683. doi: 10.1056/NEJM200205303462202. - DOI - PubMed
    1. Ott MJ, Aruda M. Hepatitis B vaccine. J Pediatr Health Care. 1999;13:211–6. doi: 10.1016/S0891-5245(99)90001-9. - DOI - PubMed
    1. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2001;34:1225–41. doi: 10.1053/jhep.2001.29401. - DOI - PubMed
    1. World Health Organization fact sheets no. 2004. available at http://who.int/mediacentre/factsheets/fs204/en.
    1. Zuckerman JN, Zuckerman AJ. The epidemiology of hepatitis B. Clin Liver Dis. 1999;3:179–187. doi: 10.1016/S1089-3261(05)70064-7. - DOI

Publication types